Table 2.
Comparison of treatment and outcome in MR patients and MS patients
| MR patients (n = 9) | MS patients (n = 64) | P value | |
|---|---|---|---|
| Antibiotics prescription | |||
| Azithromycin | 9 (100) | 64 (100) | 1 |
| Beta-lactam antibiotics | 9 (100) | 56 (88) | 0.584 |
| Doxycycline | 4 (44) | 7 (11) | 0.025 |
| Outcome | |||
| Days of hospital stay | 7 (5–29)a | 5 (3–33)a | 0.019 |
| Total febrile days | 8 (4–21)a | 7 (0–24)a | 0.085 |
| No. of febrile days >3 days | 9 (100) | 58 (91.7) | 0.341 |
| No. of febrile days >7 days | 7 (78) | 29 (45.3) | 0.07 |
| Mortality | 0 (0) | 0 (0) | |
| Morbidity | |||
| Necrotizing pneumonia | 0 (0) | 1 (1.6) | |
| Postinfectious bronchiolitis obliterans | 0 (0) | 1 (1.6) | |
Data are number of patients (percentage)
aMedian (interquartile range)